Drug ID: | NPD7893 |
Drug Name: | |
Molecular Formula: | C34H47NO4 |
Canonical SMILES: | CCCCc1oc2c(c1C(=O)c1ccc(cc1)CCCN(CCCC)CCCC)cc(cc2)C(=O)OC(C)C |
Standard InCHI: | InChI=1S/C34H47NO4/c1-6-9-14-31-32(29-24-28(19-20-30(29)39-31)34(37)38-25(4)5)33(36)27-17-15-26(16-18-27)13-12-23-35(21-10-7-2)22-11-8-3/h15-20,24-25H,6-14,21-23H2,1-5H3 |
Standard InCHIKey: | ZCENNVQCOZQSGH-UHFFFAOYSA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DNCL001864 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 9807128 |
ChEBI | |
CAS Number |
Molecular Weight | 533.35 |
ALogP | -1.9529 |
MLogP | 4.65 |
XLogP | 10.075 |
HDA | 4 |
HBD | 0 |
Rotatable Bonds | 23 |
TPSA | 59.75 |
RO5 Violation | 2 |